Article content

Vancouver-based Aurora Cannabis Inc. said Tuesday that it has made an all-share offer for CanniMed Therapeutics Inc., a fellow Canadian medical marijuana company.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Aurora Cannabis makes proposal to acquire rival medical marijuana company CanniMed Back to video

CanniMed shareholders will be entitled to receive up to $24 per CanniMed share – a premium of approximately 56.9 per cent over their Tuesday closing price of $15.30 – or 4.52586207 Aurora shares, based on the 20-day volume weighted average price of Aurora, the company said in a release.

However, based on the $6.41 closing price of Aurora shares on Tuesday, this would actually work out to 3.74415 Aurora shares for each CanniMed share, according to the release.

At Tuesday’s prices, CanniMed shareholders would hold approximately 16 per cent of the issued and outstanding shares of Aurora if the deal closes.

“Aurora and CanniMed are a great fit, truly complementary, and I am convinced we can generate even greater value by combining the two companies and aligning our efforts strategically,” said Terry Booth, chief executive of Aurora, in a press release. “Aurora has the management expertise, capital markets strength, distribution channels, brand power and growth prospects to successfully integrate CanniMed into Aurora — the fastest-growing cannabis company with the sector’s most exceptional execution track record.”